Department of External Affairs
Office of Public Affairs
Contact: John P. Broder
Vice President-External Affairs


An Important Message from Eva Chalas, MD,

Chief of Gynecological Oncology at Winthrop-University Hospital

In 1999 Congress declared September Gynecologic Cancer Awareness Month. The goal of this special designation is to raise awareness among women and healthcare providers to encourage more screenings, earlier detection and increased support for gynecological cancer research.

Cancers of the uterus, ovaries, fallopian tubes, peritoneum, vagina and vulva account for approximately 80,000 cancer diagnoses in the United States each year. This is comparable to one-third the number of cases of breast cancer in this country, and because gynecological cancers are generally associated with good prognosis when they are detected in their early stages, they have not garnered as much public attention as breast cancer and other illnesses. As a result, promotion of screening, early detection and research into the prevention, diagnosis and treatment of gynecologic cancers has lagged behind that of other diseases.

Screening & Prevention

The only gynecologic cancer for which there is currently an effective screening test is cervical cancer. Additionally, in 2006 a vaccine which can prevent 70 percent of cervical cancer cases by protecting women from the Human Papilloma Virus (HPV), was approved by the FDA. As a result of the new vaccine, as well as the wide-spread use of the Pap test, rates and mortality of cervical cancer have markedly decreased over the past five decades. In the long run, this should translate into a lower risk of cervical cancer diagnosis in American women.

Challenges in Women’s Cancer Care

The most challenging and difficult group of women’s cancers to diagnose and treat are ovarian, fallopian tube and peritoneal cancers. These conditions often present with gastrointestinal symptoms, such as abdominal bloating, and can be confused with more common conditions such as irritable bowel syndrome or diverticular disease. Two-thirds of the women who are diagnosed with these conditions are already at Stage III or Stage IV of the disease, when it has already spread extensively throughout their abdomen or into the liver or chest. If women and their healthcare providers are aware of and watchful for the signs and symptoms, this could lead to earlier diagnosis and intervention.

The most common gynecologic cancer is uterine cancer. The majority of these cases are linked to obesity, and with more than 60 percent of Americans currently overweight or obese, the Un

# # #

< < Back to menu

[ Home | Search | Contact | Directions | Privacy Notice ]

Winthrop-University Hospital | 259 First Street | Mineola NY 11501 | 516-663-0333

This site provides information as a resource. It is not a substitute for professional medical advice.
Always consult a physician or healthcare provider for treatment and guidance toward good health.
Copyright © 2008 Winthrop-University Hospital. All rights reserved. Long Island Web Design